Ghadiri Maryam, Vasheghani-Farahani Ebrahim, Atyabi Fatemeh, Kobarfard Farzad, Hosseinkhani Hossein
Biomedical Engineering Division, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.
Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res. 2017 Fall;16(4):1320-1334.
Cationic polymeric nanoparticles have great potential for developing drug delivery systems with limited side effects for tumor medication. The goal of this research is investigation of cationic dextran-spermine polymer (DS) efficacy for improvement of hydrophilic drug delivery to negatively charged cancerous cells. Capecitabine (as a hydrophilic antineoplastic drug) was loaded into the magnetic dextran-spermine nanoparticles (DS-NPs) via ionic gelation. Design of experiments was applied to specify how the significant factors affect size, surface charge and capecitabine entrapment efficiency of the DS-NPs. Physicochemical properties, release profile and cellular studies of the optimized DS-NPs were evaluated. The experimental results indicated that DS-NPs with favorable properties can be achieved at an optimized condition of 2 mg/mL DS and 0.75 mg/mL tri-polyphosphate (TPP) concentrations, TPP addition rate of 35 mL/min, pH 3 of DS solution and super paramagnetic iron oxide nanoparticles (SPION)/DS mass ratio of 0.5. The entrapment efficiency of capecitabine was 26.1% at optimum condition and drug release at neutral pH after 24 h and acidic pH within 3 h was 56 and 98%, respectively. The cytotoxicity assessment exhibited that capecitabine loaded DS-NPs was more toxic than corresponding free drug as control. Significant cellular uptake of capecitabine loaded DS-NPs by U87MG glioblastoma cells were proved by Prussian blue staining and TEM, qualitatively. DS-NPs are suitable candidates for delivery of the hydrophilic drugs in cancer treatment and due to positive charge of the dextran-spermine, the uptake of the hydrophilic drugs by the cancerous cells was improved.
阳离子聚合物纳米颗粒在开发副作用有限的肿瘤药物递送系统方面具有巨大潜力。本研究的目的是研究阳离子葡聚糖-精胺聚合物(DS)在改善亲水性药物向带负电荷癌细胞递送方面的功效。通过离子凝胶法将卡培他滨(作为亲水性抗肿瘤药物)负载到磁性葡聚糖-精胺纳米颗粒(DS-NPs)中。应用实验设计来确定显著因素如何影响DS-NPs的尺寸、表面电荷和卡培他滨包封率。对优化后的DS-NPs的物理化学性质、释放曲线和细胞研究进行了评估。实验结果表明,在2 mg/mL DS和0.75 mg/mL三聚磷酸钠(TPP)浓度、TPP添加速率为35 mL/min、DS溶液pH值为3以及超顺磁性氧化铁纳米颗粒(SPION)/DS质量比为0.5的优化条件下,可以获得具有良好性能的DS-NPs。在最佳条件下,卡培他滨的包封率为26.1%,在中性pH值下24小时后的药物释放率和酸性pH值下3小时内的药物释放率分别为56%和98%。细胞毒性评估显示,负载卡培他滨的DS-NPs比相应的游离药物对照毒性更大。普鲁士蓝染色和透射电镜定性地证明了U87MG胶质母细胞瘤细胞对负载卡培他滨的DS-NPs有显著的细胞摄取。DS-NPs是癌症治疗中亲水性药物递送的合适候选者,并且由于葡聚糖-精胺的正电荷,癌细胞对亲水性药物的摄取得到了改善。
J Biomed Mater Res A. 2017-7-14
Colloids Surf B Biointerfaces. 2015-3-1
J Biomed Nanotechnol. 2013-3
Biomolecules. 2024-7-15
Pharmaceutics. 2023-3-6
Saudi J Biol Sci. 2022-6
Nanoscale Res Lett. 2014-6-15
Carbohydr Polym. 2013-2-18
Int J Nanomedicine. 2012-11-12
Int J Nanomedicine. 2012-4-11